The Baruch S. Blumberg Institute presented the 2025 Lam Excellence in Medicinal and Chemistry Award recently to Dan Nguyen, BS, senior research scientist in medicinal chemistry, Blumberg Institute and Mark E. McDonell, PhD, director of chemistry, Fox Chase

The Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC) today welcomed NIH Director Jay Bhattacharya, MD, PhD, for a visit highlighting collaborative research, innovation and academic programs advancing public health and biomedical discovery.U.S.

Jinhong Chang, MD, PhD, was chosen for her outstanding research in molecular virology and antiviral drug discovery. The Baruch S. Blumberg Institute presented the Harvey J. Alter Chair, a newly created honor, to Jinhong Chang, MD, PhD,

Ju-Tao Guo, MD,  globally recognized expert in hepatitis B virology, will lead the Pennsylvania nonprofit research organization.Ju-Tao Guo, MD, a leading expert in hepatitis B virology, was named president of the Baruch S. Blumberg Institute by its

Dr. Sofia was responsible for the discovery and early development of sofosbuvir, which became the backbone of many hepatitis C curative therapies.Award-winning scientist Michael J. Sofia, PhD, who discovered the first reliably effective treatment for hepatitis C,

The Hepatitis B Foundation, Baruch S. Blumberg Institute and American Philosophical Society, joined together to celebrate the legacy—and the 100th birthday—of the late Baruch S. Blumberg, MD, DPhil, a Nobel Laureate, on July 29 in Philadelphia.More than

The Hepatitis B Foundation and Baruch S. Blumberg Institute recently presented Nicole E. Geracimos, MD, a Doylestown resident, with the organizations’ first Education Impact Award.Dr. Geracimos was honored at a June 26 event to raise funds for the

Eric J. Brand, a Doylestown-area resident, has been hired as the inaugural Chief People Officer for the Hepatitis B Foundation, Baruch S. Blumberg Institute, and Pennsylvania Biotechnology Center (PABC) after providing human resources support as a consultant

For the third straight year, Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), has been chosen by the Philadelphia Business Journal for its

Lifesaving research by scientists, doctors and others around our country is being threatened by what’s happening currently in Washington, D.C., say officials of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC).“Medical research